Effect of sodium zirconium cyclosilicate on hyperkalemia after parathyroidectomy in secondary hyperparathyroidism patients with maintenance hemodialysis: A randomized trial

被引：0
作者：
Kang, Jing [1 ]
Li, Sijia [2 ]
Su, Jinglin [1 ]
Xiao, Zhixue [1 ]
Zhang, Siyi [1 ,3 ]
Liu, Shuangxin [2 ]
Ge, Pingjiang [1 ,3 ]
机构：
[1] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Otolaryngol, Guangzhou, Peoples R China
[2] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Nephrol, Guangzhou, Peoples R China
[3] South China Univ Technol, Sch Med, Dept Otolaryngol, Guangzhou, Peoples R China
来源：
MEDICINE | 2024年 / 103卷 / 52期
基金：
中国国家自然科学基金;
关键词：
hemodialysis; hyperkalemia; hyperparathyroidism; parathyroidectomy; sodium zirconium cyclosilicate; INTRAOPERATIVE HYPERKALEMIA; RISK-FACTORS; SURVIVAL; MANAGEMENT; PREDICTORS; METABOLISM; DISEASE;
D O I：
10.1097/MD.0000000000040917
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background:Postoperative hyperkalemia is 1 common complication after parathyroidectomy (PTX), which requires close monitoring and prompt treatment. This study aimed to determine whether using sodium zirconium cyclosilicate (SZC) would lower the risk of hyperkalemia in patients with maintenance hemodialysis after PTX.Methods:Sixty-two patients with secondary hyperparathyroidism (SHPT) were randomly divided into the experimental and control groups. Patients in the experimental group were required to take 10 g of SZC before PTX. Laboratory chemistries were obtained before and after surgery.Results:Parathyroid hormone (PTH) decreased dramatically in the experimental and control groups after PTX. There were no significant differences in serum potassium ion (K+) between the 2 groups at 6 am on the day of surgery and immediately after surgery. However, serum potassium in the experimental group at 9 pm on the day of surgery was significantly lower than in the control group. Three patients with severe hyperkalemia in the control group received emergency hemodialysis or insulin and glucose treatment, while none in the experimental group required hemodialysis. Serum calcium levels declined immediately after the operation, but no significant differences were found between these 2 groups at all time points.Conclusion:SZC has the potential to reduce the occurrence of hyperkalemia and avoid urgent hemodialysis after PTX. We recommended that SZC could be used routinely in SHPT patients on the day of PTX surgery.
引用
收藏
页数：6
相关论文
共 29 条
  • [1] Mizobuchi M., Ogata H., Koiwa F., Secondary hyperparathyroidism: Pathogenesis and latest treatment., Ther Apher Dial, 23, pp. 309-318, (2019)
  • [2] Rodriguez-Ortiz M.E., Rodriguez M., Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease., F1000Res, 9, (2020)
  • [3] Kalantar-Zadeh K., Kuwae N., Regidor D.L., Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients., Kidney Int, 70, pp. 771-780, (2006)
  • [4] Young E.W., Albert J.M., Satayathum S., Predictors and consequences of altered mineral metabolism: The dialysis outcomes and practice patterns study., Kidney Int, 67, pp. 1179-1187, (2005)
  • [5] Fernandez-Martin J.L., Martinez-Camblor P., Dionisi M.P., Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: The COSMOS study., Nephrol Dial Transplant, 30, pp. 1542-1551, (2015)
  • [6] Fernandez-Martin J.L., Carrero J.J., Benedik M., COSMOS: The dialysis scenario of CKD-MBD in Europe., Nephrol Dial Transplant, 28, pp. 1922-1935, (2013)
  • [7] Narayan R., Perkins R.M., Berbano E.P., Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: A cost utility analysis., Am J Kidney Dis, 49, pp. 801-813, (2007)
  • [8] Bajaj Y., Roberts S., Simon D., Snowden C., Gianopoulos I., England R.J., Intra-operative hyperkalemia: A serious but under recognised complication of renal parathyroidectomy - A prospective study: How we do it., Clin Otolaryngol, 36, pp. 69-72, (2011)
  • [9] Evenepoel P., Claes K., Kuypers D., Maes B., Vanrenterghem Y., Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: A single centre study., Nephrol Dial Transplant, 20, pp. 1714-1720, (2005)
  • [10] Li S., Liu S., Chen Q., Clinical predictor of postoperative hyperkalemia after parathyroidectomy in patients with hemodialysis., Int J Surg, 53, pp. 1-4, (2018)
123